
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:0A4J | London | Ordinary Share | ASTRAZENECA ADR REPRESENTING 0.5 ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
18:20:07 | O | 0 | 64.38 | USD |
Date | Time | Source | Headline |
---|---|---|---|
23/11/2023 | 15:00 | UKREG | AstraZeneca PLC Director/PDMR Shareholding |
17/11/2023 | 07:00 | UKREG | AstraZeneca PLC Truqap approved in US for HR+ breast cancer |
14/11/2023 | 07:05 | UKREG | AstraZeneca PLC Update on PACIFIC-2 Phase III trial for Imfinzi |
09/11/2023 | 15:00 | UKREG | AstraZeneca PLC Director Declaration |
09/11/2023 | 07:10 | UKREG | AstraZeneca PLC Imfinzi combination improves PFS in liver cancer |
09/11/2023 | 07:05 | UKREG | AstraZeneca PLC Agreement with Eccogene for clinical stage GLP-1RA |
09/11/2023 | 07:00 | UKREG | AstraZeneca PLC 9M and Q3 2023 results |
01/11/2023 | 15:00 | UKREG | AstraZeneca PLC Total Voting Rights |
01/11/2023 | 07:00 | UKREG | AstraZeneca PLC AstraZeneca cell & gene therapy deal w/ Cellectis |
03/10/2023 | 06:00 | UKREG | AstraZeneca PLC AstraZeneca settles Nexium liability litigations |
Astrazeneca (0A4J) Share Charts1 Year Astrazeneca Chart |
|
1 Month Astrazeneca Chart |
Intraday Astrazeneca Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
18:20:08 | 64.38 | 3 | 0.00 | O |
18:18:13 | 64.39 | 7 | 0.00 | O |
18:07:40 | 64.33 | 6 | 0.00 | O |
17:44:44 | 64.33 | 1 | 0.00 | O |
17:38:57 | 64.28 | 3 | 0.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |